These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20870657)

  • 21. Assessing and managing risks arising from exposure to endocrine-active chemicals.
    Phillips KP; Foster WG; Leiss W; Sahni V; Karyakina N; Turner MC; Kacew S; Krewski D
    J Toxicol Environ Health B Crit Rev; 2008 Mar; 11(3-4):351-72. PubMed ID: 18368561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endocrine disruptors -- Monograph. 3. Arsenic].
    Sturchio E; Minoia C; Zanellato M; Masotti A; Leoni E; Sottani C; Biamonti G; Ronchi A; Casorri L; Signorini S; Imbriani M
    G Ital Med Lav Ergon; 2009; 31(1):5-32. PubMed ID: 19558036
    [No Abstract]   [Full Text] [Related]  

  • 23. Endocrine disruptors and timing of human exposure.
    Braw-Tal R
    Pediatr Endocrinol Rev; 2010 Sep; 8(1):41-6. PubMed ID: 21037543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of biomarkers in the assessment of health risk from environmental exposure to chemical carcinogens].
    Kostka G
    Rocz Panstw Zakl Hig; 2003; 54 Suppl():30-1. PubMed ID: 12884497
    [No Abstract]   [Full Text] [Related]  

  • 25. [Environmental endocrine disruptors and breast cancer: new risk factors?].
    Fénichel P; Brucker-Davis F
    Gynecol Obstet Fertil; 2008 Oct; 36(10):969-77. PubMed ID: 18805035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of metals as endocrine disruptors.
    Iavicoli I; Fontana L; Bergamaschi A
    J Toxicol Environ Health B Crit Rev; 2009 Mar; 12(3):206-23. PubMed ID: 19466673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodialysis and toxins: is there a risk?
    Quesnelle R
    CANNT J; 2012; 22(3):10-1. PubMed ID: 23167045
    [No Abstract]   [Full Text] [Related]  

  • 28. Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors.
    Salehi F; Turner MC; Phillips KP; Wigle DT; Krewski D; Aronson KJ
    J Toxicol Environ Health B Crit Rev; 2008 Mar; 11(3-4):276-300. PubMed ID: 18368557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk communication of endocrine-disrupting chemicals: improving knowledge translation and transfer.
    Tyshenko MG; Phillips KP; Mehta M; Poirier R; Leiss W
    J Toxicol Environ Health B Crit Rev; 2008 Mar; 11(3-4):345-50. PubMed ID: 18368560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine disruptors: a most relevant issue for the pediatric endocrinologist.
    Bourguignon JP; Söder O
    Horm Res Paediatr; 2013; 80(5):371-2. PubMed ID: 24080703
    [No Abstract]   [Full Text] [Related]  

  • 31. Possible effects of endocrine disruptors on male reproductive function.
    Mori C
    Kaibogaku Zasshi; 2001 Aug; 76(4):361-8. PubMed ID: 11577437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. More problems with plastics. Like BPA, chemicals called phthalates raise some concerns.
    Voiland A
    US News World Rep; 2008 May; 144(14):54. PubMed ID: 18702218
    [No Abstract]   [Full Text] [Related]  

  • 33. Endocrine disruptors and reproductive health: the case of bisphenol-A.
    Maffini MV; Rubin BS; Sonnenschein C; Soto AM
    Mol Cell Endocrinol; 2006 Jul; 254-255():179-86. PubMed ID: 16781053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis.
    Bolt HM; Degen GH
    Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The low-dose issue and stochastic responses to endocrine disruptors.
    Hirabayashi Y; Inoue T
    J Appl Toxicol; 2011 Jan; 31(1):84-8. PubMed ID: 20683855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical environmental factors: Can they affect acne?
    Mazioti M
    Indian J Dermatol Venereol Leprol; 2017; 83(5):522-524. PubMed ID: 28707651
    [No Abstract]   [Full Text] [Related]  

  • 37. Human exposure to endocrine disrupters and semen quality.
    Phillips KP; Tanphaichitr N
    J Toxicol Environ Health B Crit Rev; 2008 Mar; 11(3-4):188-220. PubMed ID: 18368553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human health and endocrine disruption: a simple multicriteria framework for the qualitative assessment of end point specific risks in a context of scientific uncertainty.
    Martin OV; Lester JN; Voulvoulis N; Boobis AR
    Toxicol Sci; 2007 Aug; 98(2):332-47. PubMed ID: 17255114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung cancer and environmental chemical exposure: a review of our current state of knowledge with reference to the role of hormones and hormone receptors as an increased risk factor for developing lung cancer in man.
    Fucic A; Gamulin M; Ferencic Z; Rokotov DS; Katic J; Bartonova A; Lovasic IB; Merlo DF
    Toxicol Pathol; 2010 Oct; 38(6):849-55. PubMed ID: 20805318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.